You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
Alongside some of the frontrunner resynthesis (#400), I have also been working on some other compounds for the next batch of samples to send to Syngene. (Note: CLogP values were calculated using DataWarrior (#385))
OSM-S-370, -371 and -375 were synthesised following the discussion of using cubane bioisosteres (Cubane? #379). The three cubanes were generously provided by Craig Williams at UQ.
OSM-S-372, -373 and -374 were synthesised as a suggestion following the potency discussion at the last online meeting (Meeting Discussion Point 3: Potency #390).
Compounds in progress (orange box) (from left to right)
As an amide comparison with OSM-S-375 above
In order to prevent potential inherent cytotoxicity of OSM-S-374
To reduce size of the substituent on the triazole
As a comparison with OSM-S-373
The azide is at hand and the compound may lower the CLogP
Alongside some of the frontrunner resynthesis (#400), I have also been working on some other compounds for the next batch of samples to send to Syngene. (Note: CLogP values were calculated using DataWarrior (#385))
Compounds ready to ship (green box)
Compounds in progress (orange box)
(from left to right)
SMILES
(from left to right, top to bottom)
The text was updated successfully, but these errors were encountered: